Press "Enter" to skip to content

New patent expiration for Otsuka drug ABILIFY

0
Copyright © DrugPatentWatch. Originally published at New patent expiration for Otsuka drug ABILIFY

Annual Drug Patent Expirations for ABILIFY
Annual Drug Patent Expirations for ABILIFY

Abilify is a drug marketed by Otsuka and Otsuka Pharm Co Ltd and is included in six NDAs. It is available from two suppliers. There are fifty patents protecting this drug and three Paragraph IV challenges.

ABILIFY drug price trends.

Drug patent litigation for ABILIFY.

This drug has two hundred and thirty-seven patent family members in thirty-six countries.

The generic ingredient in ABILIFY is aripiprazole. Two suppliers are listed for this compound. Additional details are available on the aripiprazole profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at New patent expiration for Otsuka drug ABILIFY
    Find your next blockbuster

    Get accurate and timely intelligence — in just a few clicks

    ✓ Free trial

    ✓ No credit card

     

    DrugPatentWatch - Make Better Decisions